|
|
|
|
|
07.04.26 - 16:06
|
Is It Too Late to Buy Costco or Merck? Are These Defensive Stocks Overbought? (24/7 Wall St.)
|
|
|
Two stocks retirement investors typically reach for in uncertain markets have risen notably in recent months. Costco Wholesale (NASDAQ: COST) is up 18.1% year to date, while Merck (NYSE: MRK) rose 14.8% since the start of the year, including 4.4% in the past month. The verdict on each is different. Costco: Premium Valuation, Premium Business ... Is It Too Late to Buy Costco or Merck? Are These Defensive Stocks Overbought?...
|
|
|
|
|
07.04.26 - 15:06
|
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. (Business Wire)
|
|
|
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN). On March 25, 2026, Merck announced that it had entered into a definitive agreement to acquire Terns.
Upon the successful closing of the tender offer, stockholders of Terns will receive $53.00 net in cash for each share of Terns common stock validly tendered and not validly withdrawn in the offer, without interest and less any applicable tax withholding. Following the purchase of shares in the tender offer, Terns will become a wholly owned subsidiary of Merck.
Merck has filed today with the U.S. Securities and Exchange Commission (the “SEC”) a tender offer statement on Schedule TO, which provides the terms of the tender offer. Additionally, Terns has filed with the SEC a solicitation/recommendation statement on Schedule 14D-9 th...
|
|
|
01.04.26 - 13:03
|
Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30 (Business Wire)
|
|
|
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its first-quarter 2026 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, April 30. During the call, company executives will provide an overview of Merck's performance for the quarter.
Investors, journalists and the general public may access a live audio webcast of the call via this weblink. A replay of the webcast, along with the sales and earnings news release, supplemental financial disclosures and slides highlighting the results, will be available at www.merck.com.
All participants may join the call by dialing (800) 369-3351 (U.S. and Canada Toll-Free) or (517) 308-9448 and using the access code 9818590.
About Merck
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have broug...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26.03.26 - 08:03
|
Merck & Co schlägt schon wieder zu – Blockbuster-Chance (Der Aktionaer)
|
|
|
Der US-amerikanische Konzern Merck & Co will sich erneut im Bereich der Onkologie verstärken. Am gestrigen Mittwoch kündigte das Pharma-Unternehmen die geplante Übernahme von Terns Pharmaceuticals an. Merck & Co hat es dabei auf TERN-701 abgesehen, einem potenziellen Blockbuster zur Behandlung einer bestimmten Form von Leukämie....
|
|
|
|
|
|
|
|
|
25.03.26 - 12:24
|
Merck To Acquire Terns For $53.00/shr (AFX)
|
|
|
KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) and Terns Pharmaceuticals (TERN), a clinical-stage oncology company, announced that the companies have entered into a definitive agreement under which Merck......
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
